Exploring the anti-atherosclerosis mechanism of ginsenoside Rb1 by integrating network pharmacology and experimental verification
Figure 4.Molecular docking between ginsenoside Rb1 and core targets protein. (A) The binding energy of molecular docking. (B) CCND1 and ginsenoside Rb1 molecular docking visualization.